Frontiers in Pharmacology | Inflammation Pharmacology

Correction

Published on 23 Jul 2024

Corrigendum: Ginsenoside compound K attenuates ox-LDL-mediated macrophage inflammation and foam cell formation via autophagy induction and modulating NF-kB, p38, and JNK MAPK signaling

in Inflammation Pharmacology

Shan Lu
Yun Luo
GuiBo Sun
XiaoBo Sun

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1452605

1,265 views

Original Research

Published on 23 Jul 2024

The relationship between dexmedetomidine administration and prognosis in patients with sepsis-induced coagulopathy: a retrospective cohort study

in Inflammation Pharmacology

Hongyu Huang
Qifei Li
Qingming Lin
Zheng Gong
Lujia Chen
Feng Chen
Xing Liao
Shirong Lin

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1414809

4,839 views
2 citations

Review

Published on 17 Jul 2024

Pericytes: jack-of-all-trades in cancer-related inflammation

in Inflammation Pharmacology

Marianna Moro
Federica Carolina Balestrero
Ambra A. Grolla

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1426033

5,659 views
4 citations

Correction

Published on 17 Jul 2024

Corrigendum: Ginsenoside Rg1 ameliorates neuroinflammation via suppression of connexin43 ubiquitination to attenuate depression

in Inflammation Pharmacology

Huiqin Wang
Yantao Yang
Songwei Yang
Siyu Ren
Juling Feng
Yangbo Liu
Haodong Chen
Naihong Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1418824

1,012 views
1 citation

Review

Published on 12 Jul 2024

The story of clobenpropit and CXCR4: can be an effective drug in cancer and autoimmune diseases?

in Inflammation Pharmacology

Mitra Abbasifard
Kowsar Bagherzadeh
Hossein Khorramdelazad

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1410104

2,737 views

Systematic Review

Published on 11 Jul 2024

Comparisons of infection events associated with tumor necrosis factor inhibitors in patients with inflammatory arthritis: A systematic review and network meta-analysis

in Inflammation Pharmacology

Ziwei Jiang
Yue Zou
Guangyao Li
Sixuan Zhao
Wei Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1376262

2,442 views
5 citations

Review

Published on 11 Jul 2024

Critical signaling molecules in the temporomandibular joint osteoarthritis under different magnitudes of mechanical stimulation

in Inflammation Pharmacology

Yuqi Liu
Fangwen Jia
Kangya Li
Chao Liang
Xiao Lin
Wei Geng
Yanxi Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1419494

3,504 views
2 citations

Correction

Published on 10 Jul 2024

Corrigendum: Xenon attenuated neonatal lipopolysaccharide exposure induced neuronal necroptosis and subsequently improved cognition in juvenile rats

in Inflammation Pharmacology

Zhimin Liao
Xiaofeng Ou
Cheng Zhou
Daqing Ma
Hailin Zhao
Han Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1438335

709 views

Original Research

Published on 08 Jul 2024

Knockout of C1q/tumor necrosis factor-related protein-9 aggravates cardiac fibrosis in diabetic mice by regulating YAP-mediated autophagy

in Inflammation Pharmacology

Shiyan Ruan
Jun Li
Shengyun Lei
Shaomeng Zhang
Dan Xu
Anju Zuo
Linxi Li
Yuan Guo

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1407883

2,206 views
3 citations

Review

Published on 08 Jul 2024

A critical appraisal of ferroptosis in Alzheimer’s and Parkinson’s disease: new insights into emerging mechanisms and therapeutic targets

in Inflammation Pharmacology

Priyanka Soni
Navneet Ammal Kaidery
Sudarshana M. Sharma
Irina Gazaryan
Sergey V. Nikulin
Dmitry M. Hushpulian
Bobby Thomas

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1390798

5,350 views
11 citations

Systematic Review

Published on 08 Jul 2024

What are the benefits of therapeutic drug monitoring in the optimization of adalimumab therapy? a systematic review and meta-analysis up to 2022

in Inflammation Pharmacology

Yun Li
Cheng Xie
Xiaoliang Ding
Ziyang Wu
Jingjing Zhang
Jianguo Zhu
Liyan Miao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1376708

1,746 views

Original Research

Published on 03 Jul 2024

Pharmacologic inhibition of dipeptidyl peptidase 1 (cathepsin C) does not block in vitro granzyme-mediated target cell killing by CD8 T or NK cells

in Inflammation Pharmacology

Vivien R. Sutton
Sally V. Watt
Hedieh Akhlaghi
David C. Cipolla
Kuan-Ju Chen
Daniel LaSala
Patrick P. McDonald
Paul A. Beavis
Isabelle Munoz
Adrian W. Hodel

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1396710

3,642 views

Original Research

Published on 01 Jul 2024

A high reticulocyte count is a risk factor for the onset of metabolic dysfunction-associated steatotic liver disease: Cross-sectional and prospective studies of data of 310,091 individuals from the UK Biobank

in Inflammation Pharmacology

Peng-Cheng Ma
Qi-Mei Li
Rui-Ning Li
Chang Hong
Hao Cui
Zi-Yong Zhang
Yan Li
Lu-Shan Xiao
Hong Zhu
Lin Zeng

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1281095

3,424 views
1 citation

Original Research

Published on 28 Jun 2024

Adenosine A2A receptor as a potential regulator of Mycobacterium leprae survival mechanisms: new insights into leprosy neural damage

in Inflammation Pharmacology

Plinio Marcos Freire dos Santos
Chyntia Carolina Díaz Acosta
Thabatta Leal Silveira Andrezo Rosa
Michelle Harumi Ishiba
André Alves Dias
Antonio Marcos Rodrigues Pereira
Luísa Domingos Gutierres
Melissa Pontes Pereira
Matheus da Silva Rocha
Patrícia Sammarco Rosa

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1399363

4,121 views
1 citation

Review

Published on 21 Jun 2024

Gut-directed therapy in Parkinson’s disease

in Inflammation Pharmacology

Laura Benvenuti
Clelia Di Salvo
Gabriele Bellini
Luisa Seguella
Francesco Rettura
Giuseppe Esposito
Luca Antonioli
Roberto Ceravolo
Nunzia Bernardini
Carolina Pellegrini

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1407925

3,629 views
3 citations

Editorial

Published on 20 Jun 2024

Editorial: Recent advances in immunometabolism

in Inflammation Pharmacology

Ishtiaq Jeelani
Allah Nawaz
Hafiz Muhammad Asif
Ishtiaq Ahmad
Arijeet K. Gattu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1422816

1,625 views
1 citation